XML 54 R43.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Description of Business (Details) $ / shares in Units, $ in Thousands |  |  | 1 Months Ended | 3 Months Ended | 4 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Dec. 21, 2016 USD ($) | Jul. 05, 2016 USD ($) | Feb. 29, 2016 | Jun. 30, 2015 USD ($) | Nov. 30, 2014 USD ($) $ / shares | Jul. 31, 2014 USD ($) $ / shares shares | Jun. 30, 2016 USD ($) | Jul. 31, 2016 USD ($) shares | Dec. 31, 2016 USD ($) $ / shares shares | Dec. 31, 2015 USD ($) $ / shares | Dec. 31, 2014 USD ($) shares | Apr. 01, 2016 item
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Number of Fabry causing mutations included in the label approved by the CHMP | item |  |  |  |  |  |  |  |  |  |  |  | 313
Net product sales |  |  |  |  |  |  |  |  | $ 4,958 |  |  |
Common stock, par value (in dollars per share) | $ / shares |  |  |  |  |  |  |  |  | $ 0.01 | $ 0.01 |  |
Net proceeds from convertible notes to pay capped call transactions |  |  |  |  |  |  |  |  | $ 13,450 |  |  |
Common Stock, Par or Stated Value Per Share | $ / shares |  |  |  |  |  |  |  |  | $ 0.01 | $ 0.01 |  |
Net proceeds from stock issued at ATM transactions |  |  |  |  |  |  |  |  | $ 97,068 |  | $ 38,636 |
Proceeds from the issuance of common stock (in dollars) |  |  |  |  |  |  |  |  | 97,068 | $ 243,042 | $ 135,805 |
Accumulated deficit |  |  |  |  |  |  |  |  | $ (779,608) | $ (579,566) |  |
Galafold | EU |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Net product sales |  |  |  |  |  |  | $ 5,000 |  |  |  |  |
Cowen and Company, LLC | Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued from ATM transactions (in shares) | shares |  |  |  |  |  |  |  | 15,000,000 |  |  |  |
Net proceeds from stock issued at ATM transactions |  |  |  |  |  |  |  | $ 97,100 |  |  |  |
Commission expenses incurred on issue of common stock |  |  |  |  |  |  |  | 2,700 |  |  |  |
Other expenses paid |  |  |  |  |  |  |  | $ 200 |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value (in dollars per share) | $ / shares |  |  |  |  | $ 0.01 |  |  |  |  |  |  |
Common Stock, Par or Stated Value Per Share | $ / shares |  |  |  |  | $ 0.01 |  |  |  |  |  |  |
Number of shares issued from ATM transactions (in shares) | shares |  |  |  |  |  |  |  |  | 14,989,027 |  | 14,328,224 |
Net proceeds from stock issued at ATM transactions |  |  |  |  |  |  |  |  | $ 150 |  | $ 143 |
Proceeds from the issuance of common stock (in dollars) |  |  |  | $ 243,000 | $ 97,200 |  |  |  |  |  |  |
Common Stock | Cowen and Company, LLC | At the market ("ATM") equity offering |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value (in dollars per share) | $ / shares |  |  |  |  |  | $ 0.01 |  |  |  |  |  |
Common Stock, Par or Stated Value Per Share | $ / shares |  |  |  |  |  | $ 0.01 |  |  |  |  |  |
Number of shares issued from ATM transactions (in shares) | shares |  |  |  |  |  | 14,300,000 |  |  |  |  |  |
Proceeds from the issuance of common stock (in dollars) |  |  |  |  |  | $ 38,600 |  |  |  |  |  |
Convertible Notes | 2016 Convertible Notes |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principle amount | $ 250,000 |  |  |  |  |  |  |  |  |  |  |
Fixed interest rate (as a percent) | 3.00% |  |  |  |  |  |  |  |  |  |  |
Proceeds from Debt, Net of Issuance Costs | $ 243,100 |  |  |  |  |  |  |  |  |  |  |
Net proceeds from convertible notes to pay capped call transactions | $ 13,500 |  |  |  |  |  |  |  |  |  |  |
Maximum |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Percentage of patients with Fabry disease caused by mutations included in the label approved by the CHMP |  |  |  |  |  |  |  |  |  |  |  | 0.5
Maximum | Cowen and Company, LLC | Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Fixed commission rate as a percentage of gross proceeds per Share sold |  |  | 3.00% |  |  |  |  | 3.00% |  |  |  |
MiaMed Inc |  |  |  |  |  |  |  |  |  |  |  |
Corporate Information, Status of Operations and Management Plans |  |  |  |  |  |  |  |  |  |  |  |
Total consideration, stock and cash |  | $ 6,500 |  |  |  |  |  |  |  |  |  |
Contingent consideration payable upon achievement of milestones |  | 83,000 |  |  |  |  |  |  |  |  |  |
Potential aggregate deal value |  | $ 89,500 |  |  |  |  |  |  |  |  |  |

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Includes payments for achievement of certain clinical, regulatory and commercial milestones. + References No definition available. + Details
Name: | fold_BusinessCombinationConsiderationTransferredIncludingMilestonePayment
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of contingent consideration payable in a business combination upon achievement of certain clinical, regulatory and commercial milestones. + References No definition available. + Details
Name: | fold_BusinessCombinationContingentConsiderationMilestones
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the commission expenses incurred for the issuance of common stock. + References No definition available. + Details
Name: | fold_CommonStockIssuanceCommissionExpenses
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the fixed commission rate, expressed as a percentage of gross proceeds per Share sold. + References No definition available. + Details
Name: | fold_FixedCommissionRateAsPercentageOfGrossProceedsPerShareSold
Namespace Prefix: | fold_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of mutations causing Fabry disease included in approved CHMP label. + References No definition available. + Details
Name: | fold_NumberOfFabryCausingMutationsIncludedInCHMPLabelApproval
Namespace Prefix: | fold_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the portion of patients with Fabry disease caused by mutations included in the label approved by the CHMP. + References No definition available. + Details
Name: | fold_PortionOfPatientsWithFabryCausedByMutationsIncludedInLabelApprovedByChmp
Namespace Prefix: | fold_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for premiums paid for capped call confirmations. + References No definition available. + Details
Name: | fold_PremiumsPaidForCappedCallConfirmations
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of new stock issued during the period related to at the market (ATM) equity offerings. + References No definition available. + Details
Name: | fold_StockIssuedDuringPeriodSharesAtMarketOffering
Namespace Prefix: | fold_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period related to at the market (ATM) equity offerings. + References No definition available. + Details
Name: | fold_StockIssuedDuringPeriodValueAtMarketOffering
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face (par) amount of debt instrument at time of issuance. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399 + Details
Name: | us-gaap_DebtInstrumentFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This element represents a sum total of expenses not separately reflected on the income statement for the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.7) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4,6) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. + References No definition available. + Details
Name: | us-gaap_ProceedsFromDebtNetOfIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueGoodsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=fold_CowenAndCompanyLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=fold_SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=fold_AtMarketEquityOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=fold_ConvertibleSeniorNotes2016Due2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=fold_MiamedIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |